Carlos Alban, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 10,072 shares at $56.71 ($574K) on 2012-02-29, disclosed to the SEC on 2012-03-02.
Scheduled sale ($574k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.71 | 1,204 | $68K | 11.9% |
| 2 | $57.04 | 8,868 | $506K | 88.1% |
| Total | $57.00 avg | 10,072 | $574K | 100% |
| Filing → |
| ABBV | SELL | 2018-03-02 | $19.1M | — | Filing → |
| ABBV | SELL | 2017-06-15 | $3.2M | — | Filing → |
| ABBV | SELL | 2017-05-08 | $2.9M | — | Filing → |